We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Sorry, we do not have enough data to show an influence graph for this author.
Learn More
ExonHit Therapeutics' mission is to be the leader in the application of alternative RNA splicing to the discovery and development of therapeutics and diagnostics for cancer and neurodegenerative diseases. The most advanced drugs in the Company's pipeline are treatments for amyotropic lateral sclerosis. One of these drugs entered Phase II trials in October(More)
  • 1